OPNURASIB
UNII Q3W0H3V1LQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Opnurasib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3W0H3V1LQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2653994-08-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3W0H3V1LQ

CAS Registry Number

2653994-08-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OPNURASIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H28ClN7O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AZUYLZMQTIKGSC-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C177916

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

156501355

Unique identification number in the NCBI database of chemical substances.

INN ID

12429

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-135

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1n(C)c2ccc(cc2c1)-c3c(c(n(C4CC5(CN(C(C=C)=O)C5)C4)n3)C)-c6c(c(C)cc7c6cn[nH]7)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Opnurasib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.